JCRファーマシューティカルズの拡大アクセスポリシー

This document outlines the policy for obtaining pre-approval access to investigational drugs developed by JCR Pharmaceuticals. As a company engaged in the research, development, manufacturing, and marketing of biopharmaceuticals and regenerative medicine, JCR focuses on providing treatment options for serious inherited disorders and life-threatening conditions. To ensure patients can benefit from these potentially transformative drugs, JCR prioritizes conducting clinical trials that meet global regulatory standards and aims for quick regulatory approval. The company reserves the right to revise this policy at any time.